Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review.
Adolescent
Asymptomatic Diseases
Autoimmune Hypophysitis
/ diagnostic imaging
Azathioprine
/ therapeutic use
Cervical Vertebrae
Female
Glucocorticoids
/ therapeutic use
Humans
Hypesthesia
/ physiopathology
Immunoglobulin G
/ immunology
Immunoglobulin G4-Related Disease
/ diagnostic imaging
Immunosuppressive Agents
/ therapeutic use
Magnetic Resonance Imaging
Myelitis
/ diagnostic imaging
Paresthesia
/ physiopathology
Pulse Therapy, Drug
Recurrence
Hypophysitis
IgG4-related disease
Longitudinally extensive transverse myelitis (LETM)
Magnetic resonance imaging (MRI)
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
15
10
2019
accepted:
11
12
2019
pubmed:
4
1
2020
medline:
10
2
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
IgG4-related disease (IgG4-RD) is a disorder with various clinical manifestations. Central nervous system (CNS) involvement is well recognized, with hypertrophic pachymeningitis and hypophysitis being the most common manifestations. Spinal cord involvement is an extremely rare manifestation. We present the first case of an IgG4-RD patient with spinal cord parenchymal disease and concurrent hypophysitis. We review also the current literature about CNS parenchymal involvement in the context of IgG4-RD. A young female presented with clinical symptoms of myelitis. Cervical spinal cord magnetic resonance imaging (MRI) displayed features of longitudinally extensive transverse myelitis (LETM). Brain MRI showed a small number of high-intensity lesions in the deep white matter and enlargement of hypophysis with homogeneous gadolinium enhancement (asymptomatic hypophysitis). Diagnostic workup revealed elevated IgG4 serum levels (146 mg/dL). Our patient fulfilled the organ-specific diagnostic criteria of IgG4-hypophysitis. Treatment with intravenous glucocorticoids led to rapid clinical response, and to the substantial resolution of imaging findings. Azathioprine was used as a maintenance treatment. One relapse occurred 2 years after the initial diagnosis and patient was re-treated with glucocorticoids. Three years after relapse, patient is in remission with azathioprine. We present the first case of myelitis with radiological features of LETM associated with increased IgG4 serum levels and the simultaneous presence of asymptomatic IgG4-related hypophysitis.
Identifiants
pubmed: 31898763
doi: 10.1007/s00296-019-04502-6
pii: 10.1007/s00296-019-04502-6
doi:
Substances chimiques
Glucocorticoids
0
Immunoglobulin G
0
Immunosuppressive Agents
0
Azathioprine
MRK240IY2L
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
337-343Références
Br J Neurosurg. 2019 Oct;33(5):570-576
pubmed: 28958166
J Clin Endocrinol Metab. 2011 Jul;96(7):1971-80
pubmed: 21593109
Arthritis Rheumatol. 2015 Jul;67(7):1688-99
pubmed: 25809420
Mod Pathol. 2012 Sep;25(9):1181-92
pubmed: 22596100
Ann Rheum Dis. 2015 Jun;74(6):1171-7
pubmed: 25667206
Lancet Neurol. 2018 Feb;17(2):183-192
pubmed: 29413316
Dtsch Med Wochenschr. 2019 Jul;144(14):965-968
pubmed: 31311046
Neuropathology. 2012 Feb;32(1):100-4
pubmed: 21615518
Hum Pathol. 2009 Nov;40(11):1611-7
pubmed: 19656549
Intern Med. 2016;55(14):1911-6
pubmed: 27432102
Neuroradiology. 2018 Jul;60(7):769-773
pubmed: 29736618
Front Immunol. 2019 Aug 13;10:1910
pubmed: 31456806
J Neurol Sci. 2012 Jul 15;318(1-2):31-5
pubmed: 22546342
Eur Spine J. 2016 May;25 Suppl 1:75-9
pubmed: 26155896
J Neurosurg Spine. 2016 Dec;25(6):790-794
pubmed: 27391401
Curr Opin Rheumatol. 2017 May;29(3):223-227
pubmed: 28319486
JAMA Neurol. 2014 Jun;71(6):785-93
pubmed: 24733677
Clin Med (Lond). 2015 Apr;15(2):130-4
pubmed: 25824063
Clin Imaging. 2017 Nov - Dec;46:108-112
pubmed: 28768224
Medicine (Baltimore). 2013 Jul;92(4):206-16
pubmed: 23793110
Medicine (Baltimore). 2017 Nov;96(47):e8709
pubmed: 29381959
Curr Treat Options Neurol. 2017 Apr;19(4):14
pubmed: 28374231
World Neurosurg. 2019 Oct;130:65-70
pubmed: 31254697
Surg Neurol Int. 2018 Oct 17;9:209
pubmed: 30488007
JAMA Neurol. 2014 Jun;71(6):767-70
pubmed: 24781034
J Clin Endocrinol Metab. 2013 May;98(5):1808-11
pubmed: 23515454
Immunol Res. 2017 Feb;65(1):386-394
pubmed: 27592235
J Neurosurg. 2011 Dec;115(6):1242-7
pubmed: 21854114
J Neurosurg Spine. 2017 Jun;26(6):688-693
pubmed: 28304239
J Neuroimmunol. 2019 Oct 15;335:577018
pubmed: 31401417
Mult Scler. 2012 Mar;18(3):271-85
pubmed: 21669935
Int J Neurosci. 2018 Nov;128(11):1097-1099
pubmed: 29584535
Neurology. 2016 Feb 2;86(5):491-2
pubmed: 26833940
Ann Indian Acad Neurol. 2019 Jan-Mar;22(1):73-78
pubmed: 30692763
Semin Arthritis Rheum. 2019 Dec;49(3):430-437
pubmed: 31155444
Ann Rheum Dis. 2019 Mar;78(3):406-412
pubmed: 30612117
World Neurosurg. 2015 Aug;84(2):591.e7-10
pubmed: 25836267
eNeurologicalSci. 2018 Jan 04;10:45-47
pubmed: 29736428
J Neurol Sci. 2014 Dec 15;347(1-2):398-400
pubmed: 25454650